Literature DB >> 11414445

Antigenic heterogeneity of lipopolysaccharide among Burkholderia pseudomallei clinical isolates.

N Anuntagool1, P Aramsri, T Panichakul, V R Wuthiekanun, R Kinoshita, N J White, S Sirisinha.   

Abstract

Burkholderia pseudomallei (BP) causes melioidosis, a potentially fatal human infection in the tropics. Clinical isolates from different geographical locations have similar morphological and biochemical characteristics. Although BP has been reported to possess 2 types of lipopolysaccharide (LPS) differing in the chemical structure of their O-polysaccharide (O-PS) component, earlier report demonstrated that the clinical strains exhibited identical LPS moieties. Recently, we reported antigenic similarity between the pathogenic (Ara-) and nonpathogenic (Ara+) biotypes. However, a few clinical isolates showed atypical SDS-PAGE profiles. In this study, LPS from 739 BP isolated from patients and animals in different geographical areas were extracted by proteinase K digestion method. Their SDS-PAGE profiles and their immunoreactivities with patients' sera and monoclonal antibody (MAb) to LPS were analyzed. The isolates showed 3 LPS patterns differing in the number and electrical mobility of bands in silver-stained gel. A majority of BP (711) isolates exhibited identical typical ladder pattern, 21 isolates showed atypical ladder pattern and 7 isolates did not exhibit ladder appearance. However, all LPS preparations exhibited similar endotoxic activity as determined by Limulus amebocyte lysate assay. On the other hand, there were no immunological cross reactivity between typical and atypical LPS, as judged from Western blot against homologous and heterologous sera from melioidosis patients from whom the typical and atypical LPS were isolated. Nevertheless, a Western blot profile of the typical LPS showed some variations when probed with MAb against BP LPS (9D5). Heat-killed bacteria from all LPS groups could similarly activate mouse macrophage cell line to produce nitric oxide (NO) and inducible NO synthase (iNOS).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11414445

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  13 in total

Review 1.  Laboratory diagnosis of melioidosis: past, present and future.

Authors:  Susanna K P Lau; Siddharth Sridhar; Chi-Chun Ho; Wang-Ngai Chow; Kim-Chung Lee; Ching-Wan Lam; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

Review 2.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

Review 3.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.

Authors:  Wildaliz Nieves; Saja Asakrah; Omar Qazi; Katherine A Brown; Jonathan Kurtz; David P Aucoin; James B McLachlan; Chad J Roy; Lisa A Morici
Journal:  Vaccine       Date:  2011-08-24       Impact factor: 3.641

5.  Temperature-regulated microcolony formation by Burkholderia pseudomallei requires pilA and enhances association with cultured human cells.

Authors:  Justin A Boddey; Cameron P Flegg; Chris J Day; Ifor R Beacham; Ian R Peak
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

6.  Genomic diversity of Burkholderia pseudomallei clinical isolates: subtractive hybridization reveals a Burkholderia mallei-specific prophage in B. pseudomallei 1026b.

Authors:  David DeShazer
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

7.  Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia mallei.

Authors:  Donald E Woods; Jeffrey A Jeddeloh; David L Fritz; David DeShazer
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

8.  Burkholderia mallei cellular interactions in a respiratory cell model.

Authors:  Gregory C Whitlock; Gustavo A Valbuena; Vsevolod L Popov; Barbara M Judy; D Mark Estes; Alfredo G Torres
Journal:  J Med Microbiol       Date:  2009-05       Impact factor: 2.472

9.  Seronegative bacteremic melioidosis caused by Burkholderia pseudomallei with ambiguous biochemical profile: clinical importance of accurate identification by 16S rRNA gene and groEL gene sequencing.

Authors:  Patrick C Y Woo; Susanna K P Lau; Gibson K S Woo; Ami M Y Fung; Antonio H Y Ngan; Wai-Ting Hui; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.

Authors:  David P AuCoin; Dana E Reed; Nicole L Marlenee; Richard A Bowen; Peter Thorkildson; Barbara M Judy; Alfredo G Torres; Thomas R Kozel
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.